Abbvie Inc
Change company Symbol lookup
Select an option...
ABBV Abbvie Inc
EOSE Eos Energy Enterprises Inc
GME GameStop Corp
FTDR Frontdoor Inc
HD Home Depot Inc
SRCE 1st Source Corp
PNC PNC Financial Services Group Inc
AAPL Apple Inc
MSFT Microsoft Corp
FAZE FaZe Holdings Inc
Go

Health Care : Biotechnology | Large Cap Value
Company profile

AbbVie Inc. (AbbVie) is a diversified research-based biopharmaceutical company. The Company is engaged in the research and development, manufacturing, commercialization and sale of medicines and therapies. It offers products in various therapeutic categories, including immunology products, which include Humira, Skyrizi and Rinvoq; oncology products, which include Imbruvica and Venclexta/Venclyxto; aesthetics products that include Botox Cosmetic, The Juvederm Collection of Fillers and others; neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; eye care products, which consists of Lumigan/Ganfort, Alphagan/Combigan and Restasis, and other key products, which include Mavyret/Maviret, Creon, Lupron, Linzess/Constella and Synthroid. Its products are sold to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from the AbbVie-owned distribution centers and public warehouses.

Postmarket

Last Trade
Delayed
$149.00
Change Since Close

Change Since Close

Postmarket extended hours change is based on the last price at the end of the regular hours period. Premarket extended hours change is based on the day's regular session close.

0.75 (0.51%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$148.25
Day's Change
-0.81 (-0.54%)
Bid
--
Ask
--
B/A Size
--
Day's High
148.86
Day's Low
146.72
Volume
(Average)
Volume:
3,827,791

10-day average volume:
3,898,043
3,827,791
Historical quotes & splits

Ocugen Inc. Stock Rises Wednesday, Outperforms Market

5:16 pm ET May 10, 2023 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Ocugen Inc. (OCGN) rallied 2.51% to $0.75 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.45% to 4,137.64 and the Dow Jones Industrial Average falling 0.09% to 33,531.33.

This was the stock's fourth consecutive day of gains.

Ocugen Inc. closed $2.36 short of its 52-week high ($3.11), which the company achieved on July 8th.

Trading volume (5.4 M) remained 1.1 million below its 50-day average volume of 6.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled May 10, 2023.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

May 10, 2023 17:16 ET (21:16 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.

3rd Party Research Disclosure